Preview Newsletter

Ethicon Media Monitoring 6/19/17

    Client Attorney Privileged/Attorney Work Product/At Request of Counsel

    Online Sources

  1. 'Nothing has been achieved' - anti-mesh campaigners

    Jun 19, 2017 | Radio New Zealand

    A group supporting people with complications from the use of surgical mesh says it is alarmed at a lack of action over the problem.
  2. New Report Documents History of Women’s Exposure to Dangerous Drugs and Devices

    Jun 16, 2017 | Corporate Crime Reporter

    Women are disproportionately exposed to dangerous drugs and medical devices that tear them apart from the inside out.
  3. Full Text of Stories Below

    Client Attorney Privileged/Attorney Work Product/At Request of Counsel

    Online Sources

  1. 'Nothing has been achieved' - anti-mesh campaigners

    Jun 19, 2017 | Radio New Zealand

    A group supporting people with complications from the use of surgical mesh says it is alarmed at a lack of action over the problem.

    It has been three years since the Health Select Committee began enquiring into the use of surgical mesh, and almost exactly a year since it made seven recommendations.

    But anti-mesh campaigners say surgeons are still using it without fully informing patients about risks, and no government agency knows how many surgeons are still using mesh.

    Mesh Down Under campaigner Charlotte Korte told Nine To Noon it was unacceptable.

    "When you look at where we were in 2014 and where we are now, nothing really much has been achieved. There's no register, there's no coding for mesh. In fact we met with ACC recently, in March or May actually, and there was still no coding for mesh in their system."

    She held the National-led government responsible for the lack of action, as one of its MPs chaired the Health Select Committee, she said.

    Ms Korte added that 780 decisions have been made about claims, but there was still no broader picture or register of adverse events reported to ACC or other agencies.  

    "It's going to give more information about the decisions that have already been made but it's not going to give us a picture of how many people are suffering, and this is what we asked [for] back in 2014. We need to know how many people are suffering with surgical mesh complications."

    Royal Australian and New Zealand College of Obstetricians and Gynaecologists chairman Ian Page said the product was still being used for pelvic organ prolapse.  

    But he said it was not being used as much as it once was, in recognition of the product's complications, which could occur as many as six or eight years after its insertion.  

    "We've dissuaded people from using it as a primary procedure. You have to remember that prolapse itself is quite distressing, and that's why women come seeking treatment."

    http://www.radionz.co.nz/national/programmes/ninetonoon/audio/201848002/nothing-has-been-achieved-anti-mesh-campaigners

    Return to headline | Return to top

  2. New Report Documents History of Women’s Exposure to Dangerous Drugs and Devices

    Jun 16, 2017 | Corporate Crime Reporter

    Women are disproportionately exposed to dangerous drugs and medical devices that tear them apart from the inside out.

    That’s according to a report released by the American Association for Justice (AAJ).

    From Accutane to Zonite: A History of Dangerous Drugs & Devices Marketed to Women profiles some of the most harmful medical products that have been marketed to women and highlights the important role the civil justice system has played as a backstop to enhance safety standards when regulations and all other safeguards fail.

    Women suffer from serious injuries and death after being treated with dangerous drugs and devices, such as Yaz, Essure, and vaginal mesh.

    Mounting tragedies haven’t been enough to compel corporations to pull their dangerous products from the market.

    Empowered by the courts, women have been able to publicly expose dangerous medical products and corporate wrongdoing – forcing recalls, enhancing warnings, and saving lives.

    “This timely report sheds light on the disturbing ways women have been preyed upon by corporations in the name of profit,” said Julie Braman Kane, President of AAJ.  “More than a century of gender inequality in research and unhindered corporate greed continue to put women at risk of exposure to dangerous drugs and medical devices.  We must protect women’s access to justice to ensure they can end their silent suffering and hold corporations accountable when corporations refuse to put Americans’ safety first.”

    Legislation currently pending in the U.S. House of Representatives (H.R. 1215), puts women’s health at greater risk, Kane said.

    The bill doesn’t improve patient protections, but instead denies patients who are injured or killed by even the intentional acts of a health care provider access to justice and the courts, Kane said.

    Women who have suffered serious injury would be further victimized by a provision in the bill that would grant blanket immunity to health care providers who prescribe a drug or device that was at any point approved by the Food and Drug Administration – even if that drug or device has since been proven to be dangerous, she said.

    “Congress should be ashamed of masquerading corporate handouts as patient protections,” Kane said. “This vengeful legislation severs Americans’ access to the courts, impedes state laws, and protects only those drug and device manufacturers and healthcare providers that cause our loved ones harm.”

    https://www.corporatecrimereporter.com/news/200/new-report-documents-history-womens-exposure-dangerous-drugs-devices/

    Return to headline | Return to top

  3. Full Text of Stories Below

Add recipients

Suggested